Zhejiang Tianyu Pharmaceutical Co Ltd. Stock Analysis 300702.SZ

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical active pharmaceutical ingredients (API) and intermediates. The company is headquartered in Taizhou, Zhejiang and currently employs 4,686 full-time employees. The company went IPO on 2017-09-19. The firm is mainly engaged in the generic APIs and intermediates business, Contract Development and Manufacturing Organization (CDMO) APIs and intermediates business, and formulations business. The firm's products include antihypertensive, antiasthmatic, antidiabetic, lipid-lowering, and anticoagulant drugs. The firm's products and solutions are mainly applied in the treatment of hypertension, asthma, diabetes, hyperlipidemia, and coagulation disorders. The firm mainly operates in the domestic and overseas markets.